IL-27 alleviates airway remodeling in a mouse model of asthma via PI3K/Akt pathway

References

• Holgate ST. Pathogenesis of asthma. Clin Exp Allergy. 2008;38(6):872–897. doi:10.1111/j.1365-2222.2008.02971.x.
   PubMed Web of Science ®Google Scholar
• Gibeon D, Menzies-Gow A. Recent changes in the drug treatment of allergic asthma. Clin Med. 2013;13(5):477–481. doi:10.7861/clinmedicine.13-5-477.
   PubMed Web of Science ®Google Scholar
• Sheshadri A, Castro M, Chen A. Bronchial thermoplasty: a novel therapy for severe asthma. Clin Chest Med. 2013;34(3):437–444. doi:10.1016/j.ccm.2013.03.003.
   PubMed Web of Science ®Google Scholar
• Hall C, Nici L, Sood S, ZuWallack R, Castro M. Nonpharmacologic therapy for severe persistent asthma. J Allergy Clin Immunol Pract. 2017;5(4):928–935. doi:10.1016/j.jaip.2017.04.030.
   PubMed Web of Science ®Google Scholar
• Hirota N, Martin JG. Mechanisms of airway remodeling. Chest. 2013;144(3):1026–1032. doi:10.1378/chest.12-3073.
   PubMed Web of Science ®Google Scholar
• Pflanz S, Timans JC, Cheung J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity. 2002;16(6):779–790. doi:10.1016/S1074-7613(02)00324-2.
   PubMed Web of Science ®Google Scholar
• Awasthi A, Carrier Y, Peron JP, et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol. 2007;8(12):1380–1389. doi:10.1038/ni1541.
   PubMed Web of Science ®Google Scholar
• Kalliolias GD, Ivashkiv LB. IL-27 activates human monocytes via STAT1 and suppresses IL-10 production but the inflammatory functions of IL-27 are abrogated by TLRs and p38. J Immunol. 2008;180(9):6325–6333. doi:10.4049/jimmunol.180.9.6325.
   PubMed Web of Science ®Google Scholar
• Wang Q, Liu J. Regulation and Immune Function of IL-27. Adv Exp Med Biol. 2016;941:191–211. doi:10.1007/978-94-024-0921-5_9.
   PubMed Web of Science ®Google Scholar
• Yoshimoto T, Yoshimoto T, Yasuda K, Mizuguchi J, Nakanishi K. IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: a novel therapeutic way for Th2-mediated allergic inflammation. J Immunol. 2007;179(7):4415–4423. doi:10.4049/jimmunol.179.7.4415.
   PubMed Web of Science ®Google Scholar
• Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B. The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol. 2010;11(5):329–341. doi:10.1038/nrm2882.
   PubMed Web of Science ®Google Scholar
• Alzahrani AS. PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside. Semin Cancer Biol. 2019;59:125–132.
   PubMed Web of Science ®Google Scholar
• Shepherd PR, Withers DJ, Siddle K. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J. 1998;333 (3):471–490. doi:10.1042/bj3330471.
   PubMedGoogle Scholar
• Lin HY, Xu L, Xie SS, et al. Mesenchymal stem cells suppress lung inflammation and airway remodeling in chronic asthma rat model via PI3K/Akt signaling pathway. Int J Clin Exp Pathol. 2015;8(8):8958–8967.
   PubMed Web of Science ®Google Scholar
• Liu Y, Miao Y, Gao X, et al. MicroRNA-200a affects the proliferation of airway smooth muscle cells and airway remodeling by targeting FOXC1 via the PI3K/AKT signaling pathway in ovalbumin-induced asthmatic mice. Cell Physiol Biochem. 2018;50(6):2365–2389. doi:10.1159/000495097.
   PubMedGoogle Scholar
• Zhang Z, Zhou B, Zhang K, Song Y, Zhang L, Xi M. IL-27 suppresses SKOV3 cells proliferation by enhancing STAT3 and inhibiting the Akt signal pathway. Mol Immunol. 2016;78:155–163. doi:10.1016/j.molimm.2016.09.014.
   PubMed Web of Science ®Google Scholar
• Su X, Pan J, Bai F, et al. IL-27 attenuates airway inflammation in a mouse asthma model via the STAT1 and GADD45gamma/p38 MAPK pathways. J Transl Med. 2016;14(1):283. doi:10.1186/s12967-016-1039-x.
   PubMedGoogle Scholar
• Al-Muhsen S, Johnson JR, Hamid Q. Remodeling in asthma. J Allergy Clin Immunol. 2011;128(3):451–462. quiz 463-454. doi:10.1016/j.jaci.2011.04.047.
   PubMed Web of Science ®Google Scholar
• Rosethorne EM, Charlton SJ. Airway remodeling disease: primary human structural cells and phenotypic and pathway assays to identify targets with potential to prevent or reverse remodeling. JEP. 2018; 10:75–85. doi:10.2147/JEP.S159124.
   Google Scholar
• Boulet LP. Airway remodeling in asthma: update on mechanisms and therapeutic approaches. Curr Opin Pulm Med. 2018;24(1):56–62. doi:10.1097/MCP.0000000000000441.
   PubMed Web of Science ®Google Scholar
• Dong Z, Lu X, Yang Y, et al. IL-27 alleviates the bleomycin-induced pulmonary fibrosis by regulating the Th17 cell differentiation. BMC Pulm Med. 2015;15(1):13. doi:10.1186/s12890-015-0012-4.
   PubMedGoogle Scholar
• Dong Z, Zhao X, Tai W, et al. IL-27 attenuates the TGF-beta1-induced proliferation, differentiation and collagen synthesis in lung fibroblasts. Life Sci. 2016;146:24–33. doi:10.1016/j.lfs.2016.01.004.
   PubMed Web of Science ®Google Scholar
• Hamid Q, Tulic M. Immunobiology of asthma. Annu Rev Physiol. 2009;71(1):489–507. doi:10.1146/annurev.physiol.010908.163200.
   PubMedGoogle Scholar
• Yang ZC, Yi MJ, Shan YC, et al. Targeted inhibition of Six1 attenuates allergic airway inflammation and remodeling in asthmatic mice. Biomed Pharmacother. 2016;84:1820–1825. doi:10.1016/j.biopha.2016.10.090.
   PubMed Web of Science ®Google Scholar
• Black JL, Roth M, Lee J, Carlin S, Johnson PR. Mechanisms of airway remodeling. Airway smooth muscle. Am J Respir Crit Care Med. 2001;164(supplement_2):S63–S66. doi:10.1164/ajrccm.164.supplement_2.2106059.
   PubMedGoogle Scholar
• Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet. 1989;1(8637):520–524. doi:10.1016/S0140-6736(89)90067-6.
   PubMed Web of Science ®Google Scholar
• Stumm CL, Wettlaufer SH, Jancar S, Peters-Golden M. Airway remodeling in murine asthma correlates with a defect in PGE2 synthesis by lung fibroblasts. Am J Physiol Lung Cell Mol Physiol. 2011;301(5):L636–644. doi:10.1152/ajplung.00158.2011.
   PubMed Web of Science ®Google Scholar
• Wang J, Li F, Yang M, et al. FIZZ1 promotes airway remodeling through the PI3K/Akt signaling pathway in asthma. Exp Ther Med. 2014;7(5):1265–1270. doi:10.3892/etm.2014.1580.
   PubMed Web of Science ®Google Scholar
• Duan W, Aguinaldo Datiles AM, Leung BP, Vlahos CJ, Wong WS. An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model. Int Immunopharmacol. 2005;5(3):495–502. doi:10.1016/j.intimp.2004.10.015.
   PubMed Web of Science ®Google Scholar